- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Low-Dose Imaging Effective for Ruling Out CAD
HealthDay News - Coronary computed tomography may provide alternative to catheter-based angiography
HealthDay News - Low-dose coronary computed tomography (CT) appears as sensitive as catheter-based angiography and may provide a non-invasive alternative to the latter for ruling out coronary artery disease (CAD) in symptomatic patients, according to a meta-analysis published in the March 15 issue of the Annals of Internal Medicine.
Moritz Wyler von Ballmoos, MD, PhD, MPH, of the Harvard School of Public Health in Boston, and colleagues analyzed 16 studies comprising 960 patients to summarize current evidence on the ability of low-dose coronary CT for ruling out CAD in symptomatic adults.
The researchers determined the sensitivity and specificity of the technique to be 1.00 and 0.89, respectively, at the patient level. The pooled vessel- and segment-level estimates had lower sensitivity and higher specificity than did the patient-level estimates. The researchers found statistically significant heterogeneity between studies for vessel- and segment-level estimates, and this seemed to be related to body mass index and prevalence of CAD, though not with CT scanner characteristics. The researchers concluded that evidence suggests low-dose coronary CT angiography matches catheter-based angiography's sensitivity with low radiation exposure and may be a valid alternative to catheter angiography for triaging symptomatic patients with a suspicion of CAD.
"This noninvasive technique is associated with a low effective radiation dose of 2.7 mSv. However, our meta-analysis is based on a small number of studies, many of which were done at a single academic site and presumably with the same expert operators. Further studies are therefore needed before widespread diffusion of the technology can be recommended," the authors write.
AbstractFull Text (subscription or payment may be required)
Copyright © 2011 HealthDay. All rights reserved.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
